Basel Biomed Symposium 2025
On Friday, May 23, 2025, we will celebrate the laying of the foundation stone of the new building for the Department of Biomedicine at the University of Basel. We are using this occasion to launch the Basel Biomed Symposium.
The Basel Biomed Symposium aims to promote scientific networking, cooperation and innovation across the impressive Basel life Science ecosystem. In four sessions, the 1st Basel Biomed Symposium will highlight value chains of biomedical research from basic biology to clinical application and focus on the topics: “From Cell Biology to Cell and Tissue Engineering and Therapy”, “From Neurosience to Neurology”, “From Molecular Pathways to Personalized Medicine and Cancer Therapy” and “Digital Medicine and AI in Medicine”. The symposium will begin on May 23, 2025 at 09:00 and end with an aperitif in the late afternoon.
Researchers from the University of Basel, University Hospital Basel, University Children's Hospital Basel, the D-BSSE of ETH Zurich, the FMI, the IOB, the BRCCH, the FHNW, as well as from Roche and Novartis will contribute to the Biomed Basel Symposium 2025.
Scientific Board of the Basel Biomed Symposium
- Prof. Dr. Primo Schär, Vice President for Research, University of Basel
- Prof. Dr. Alex Schier, Head Department Biozentrum, University of Basel
- Prof. Dr. Ivan Martin, Head Department of Biomedicine, University of Basel
- Prof. Dr. Jürg Steiger, Chief Medical Director, University Hospital
- Prof. Dr. Daniel Müller, Department BSSE, ETH Zürich
- Dr. Annette Luther, Hoffmann-La Roche
- Dr. Michaela Kneissel, Global Head Diseases of Aging and Regenerative Medicine, Novartis
